Business Context and Reporting Period
This Form 8-K Current Report from Spruce Biosciences, Inc. (SPRB) covers events occurring on July 22, 2025, with the report filed on July 24, 2025. The filing primarily details the results of the 2025 Annual Meeting of Stockholders and the subsequent implementation of a reverse stock split.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes; it does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The only quantitative data provided relates to share counts and voting results.
- Shares Outstanding (Record Date): 42,231,285 shares as of May 30, 2025.
- Trading Venue: OTCQB (pre-split); scheduled to move to OTC Pink Marketplace post-split.
Material Changes
Reverse Stock Split
Stockholders approved a reverse stock split with a ratio between 1:50 and 1:100. The Board of Directors subsequently approved a specific 1-for-75 (1:75) ratio. Key details include:
- Effective Date: August 4, 2025.
- Trading Resumption: August 5, 2025, on the OTC Pink Marketplace under ticker "SPRB."
- Impact: Every 75 shares convert to 1 share. No fractional shares will be issued; cash will be paid in lieu of fractions.
- Derivatives: Warrants, options, and RSUs will be adjusted with a corresponding increase in exercise prices.
- Nasdaq Compliance: The company aims to resume trading on the Nasdaq Capital Market if it meets the minimum bid price requirement for 20 consecutive trading days following the effective date.
- New CUSIP: 85209E 208.
Annual Meeting Voting Results
The following proposals were voted on at the Annual Meeting held on July 22, 2025:
| Proposal | Votes For | Votes Against/Withheld | Abstentions/Non-Votes | Outcome |
|---|---|---|---|---|
| 1. Election of Directors (Class II) |
Varied by candidate | Varied by candidate | 14,642,113 (Broker Non-Votes) | Passed |
| 2. Ratification of Auditor (BDO USA, LLP) |
29,640,903 | 1,588,035 | 370,723 | Passed |
| 3. Reverse Stock Split (1:50 to 1:100) |
48,661,894 | 4,082,624 | 855,143 | Passed |
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance or management commentary on operational outlook. The primary risk disclosed relates to the trading venue transition. While the stock will trade on the OTC Pink Marketplace immediately following the split, resumption of trading on the Nasdaq Capital Market is conditional upon maintaining the minimum bid price requirement for 20 consecutive trading days. Failure to meet this requirement could result in continued delisting from Nasdaq.
Investor Verification Checklist
- Verify the 1:75 reverse stock split adjustment on brokerage accounts effective August 4, 2025.
- Confirm the new CUSIP number (85209E 208) for post-split shares.
- Monitor the stock price on the OTC Pink Marketplace starting August 5, 2025, to assess progress toward the 20-day Nasdaq minimum bid price requirement.
- Review the impact of the split on the exercise price and share count of any outstanding options, warrants, or RSUs held.
- Check for cash payments in lieu of fractional shares if applicable to the investor's holding.